127 related articles for article (PubMed ID: 38833137)
1. The Clinicopathological Significance of Tumor Cell Subtyping in Appendiceal Neuroendocrine Tumors: A Series of 135 Tumors.
Mete O; Dodington DW; Shen DL; Asa SL
Endocr Pathol; 2024 Jun; 35(2):107-112. PubMed ID: 38833137
[TBL] [Abstract][Full Text] [Related]
2. Appendiceal Well-Differentiated Neuroendocrine Tumors: A Single-Center Experience and New Insights into the Effective Use of Immunohistochemistry.
Shibahara Y; Krzyzanowska M; Vajpeyi R
Int J Surg Pathol; 2023 May; 31(3):252-259. PubMed ID: 35491663
[No Abstract] [Full Text] [Related]
3. Risk factors for progression of appendiceal neuroendocrine tumours: low-stage tumours <5 mm appear to be overwhelmingly indolent and may merit a separate designation.
Noor M; Huber AR; Cates JMM; Gonzalez RS
Histopathology; 2021 Sep; 79(3):416-426. PubMed ID: 33754384
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience.
Koyuncuer A; Canbak T; Acar A; Şahin O
Indian J Pathol Microbiol; 2024 Apr; 67(2):282-288. PubMed ID: 38427752
[TBL] [Abstract][Full Text] [Related]
5. Paediatric appendiceal neuroendocrine tumours: a review of 33 cases from a single center.
Yalçın B; Karnak İ; Orhan D; Oğuz B; Aydın B; Kurucu N; Varan A; Kutluk T
ANZ J Surg; 2022 Apr; 92(4):742-746. PubMed ID: 34664383
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine neoplasms of the appendix: Characterization of 335 patients referred to the Copenhagen NET Center of Excellence.
Holmager P; Willemoe GL; Nielsen K; Grøndahl V; Klose M; Andreassen M; Langer SW; Hansen CP; Kjær A; Federspiel BH; Knigge U
Eur J Surg Oncol; 2021 Jun; 47(6):1357-1363. PubMed ID: 33589240
[TBL] [Abstract][Full Text] [Related]
7. [Appendiceal neuroendocrine tumor with lymph node metastasis in a teenager].
Kim KY; Park WC
Korean J Gastroenterol; 2015 Feb; 65(2):127-31. PubMed ID: 25716717
[TBL] [Abstract][Full Text] [Related]
8. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular Invasion Is Associated with Lymph Node Involvement in Small Appendiceal Neuroendocrine Tumors.
Blakely AM; Raoof M; Ituarte PHG; Fong Y; Singh G; Lee B
Ann Surg Oncol; 2019 Nov; 26(12):4008-4015. PubMed ID: 31359272
[TBL] [Abstract][Full Text] [Related]
10. Challenging the Current Risk Factors of Appendiceal Neuroendocrine Neoplasms: Can They Accurately Predict Local Lymph Nodal Invasion? Results from a Large Case Series.
Galanopoulos M; McFadyen R; Drami I; Naik R; Evans N; Luong TV; Watkins J; Caplin M; Toumpanakis C
Neuroendocrinology; 2019; 109(2):179-186. PubMed ID: 31060039
[TBL] [Abstract][Full Text] [Related]
11. Single-incision laparoscopic ileocecal resection in a 10-year-old child with appendiceal neuroendocrine tumor.
Goto A; Matsuhashi N; Takahashi T; Sato Y; Hirata S; Tanahashi T; Matsui S; Imai H; Tanaka Y; Yamaguchi K; Yoshida K
World J Surg Oncol; 2019 Nov; 17(1):197. PubMed ID: 31771590
[TBL] [Abstract][Full Text] [Related]
12. Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis.
Kim JY; Kim KS; Kim KJ; Park IJ; Lee JL; Myung SJ; Park Y; Park YS; Yu CS; Kim JC; Yu E; Jang HJ; Hong SM
Am J Surg Pathol; 2015 May; 39(5):632-43. PubMed ID: 25724002
[TBL] [Abstract][Full Text] [Related]
13. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.
Hermann G; Konukiewitz B; Schmitt A; Perren A; Klöppel G
Virchows Arch; 2011 Aug; 459(2):147-54. PubMed ID: 21739268
[TBL] [Abstract][Full Text] [Related]
14. Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE).
Rault-Petit B; Do Cao C; Guyétant S; Guimbaud R; Rohmer V; Julié C; Baudin E; Goichot B; Coriat R; Tabarin A; Ramos J; Goudet P; Hervieu V; Scoazec JY; Walter T
Ann Surg; 2019 Jul; 270(1):165-171. PubMed ID: 29557879
[TBL] [Abstract][Full Text] [Related]
15. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype.
Hsu C; Rashid A; Xing Y; Chiang YJ; Chagpar RB; Fournier KF; Chang GJ; You YN; Feig BW; Cormier JN
J Surg Oncol; 2013 Feb; 107(2):136-43. PubMed ID: 22767417
[TBL] [Abstract][Full Text] [Related]
16. Does mesoappendix infiltration predict a worse prognosis in incidental neuroendocrine tumors of the appendix? A clinicopathologic and immunohistochemical study of 15 cases.
Rossi G; Valli R; Bertolini F; Sighinolfi P; Losi L; Cavazza A; Rivasi F; Luppi G
Am J Clin Pathol; 2003 Nov; 120(5):706-11. PubMed ID: 14608896
[TBL] [Abstract][Full Text] [Related]
17. Well-Differentiated Neuroendocrine Tumors of the Appendix in Children and Adolescents: A Clinicopathologic Study.
Simon CT; Ehrlich P; Hryhorczuk A; Rabah R; Sedig L; Stoll T; Heider A
Pediatr Dev Pathol; 2023; 26(3):250-258. PubMed ID: 37334832
[TBL] [Abstract][Full Text] [Related]
18. Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.
Nesti C; Bräutigam K; Benavent M; Bernal L; Boharoon H; Botling J; Bouroumeau A; Brcic I; Brunner M; Cadiot G; Camara M; Christ E; Clerici T; Clift AK; Clouston H; Cobianchi L; Ćwikła JB; Daskalakis K; Frilling A; Garcia-Carbonero R; Grozinsky-Glasberg S; Hernando J; Hervieu V; Hofland J; Holmager P; Inzani F; Jann H; Jimenez-Fonseca P; Kaçmaz E; Kaemmerer D; Kaltsas G; Klimacek B; Knigge U; Kolasińska-Ćwikła A; Kolb W; Kos-Kudła B; Kunze CA; Landolfi S; La Rosa S; López CL; Lorenz K; Matter M; Mazal P; Mestre-Alagarda C; Del Burgo PM; van Dijkum EJMN; Oleinikov K; Orci LA; Panzuto F; Pavel M; Perrier M; Reims HM; Rindi G; Rinke A; Rinzivillo M; Sagaert X; Satiroglu I; Selberherr A; Siebenhüner AR; Tesselaar MET; Thalhammer MJ; Thiis-Evensen E; Toumpanakis C; Vandamme T; van den Berg JG; Vanoli A; van Velthuysen MF; Verslype C; Vorburger SA; Lugli A; Ramage J; Zwahlen M; Perren A; Kaderli RM
Lancet Oncol; 2023 Feb; 24(2):187-194. PubMed ID: 36640790
[TBL] [Abstract][Full Text] [Related]
19. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
Bellizzi AM
Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
[TBL] [Abstract][Full Text] [Related]
20. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
Park HY; Kwon MJ; Kang HS; Kim YJ; Kim NY; Kim MJ; Min KW; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Lee HK
Hum Pathol; 2019 May; 87():83-94. PubMed ID: 30851333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
